Literature DB >> 22512020

The available time window for embryo transfer in the rhesus monkey (Macaca mulatta).

Yongchang Chen1, Yuyu Niu, Shihua Yang, Xiechao He, Shaohui Ji, Wei Si, Xianghui Tang, Yunhua Xie, Hong Wang, Yongqing Lu, Qi Zhou, Weizhi Ji.   

Abstract

Much effort has been focused on improving assisted reproductive technology procedures in humans and nonhuman primates (NHPs). However, the pregnancy rate after embryo transfer (ET) has not been satisfactory, indicating that some barriers still need to be overcome in this important procedure. One of the key factors is embryo–uterine synchronicity, which is little known in NHPs. The objective of this study was to investigate the available ET time window in rhesus monkey (Macaca mulatta). Eighty-two adult female rhesus monkeys were superovulated with recombinant human FSH. Ovarian phases were identified according to estrogen (E2) and progesterone (P4) levels as well as ovarian examination by ultrasonography and laparoscopy. A total of 259 embryos were transferred by the laparoscopic approach into the oviducts of 63 adult female monkeys. Ovarian phases were divided into late follicular and early luteal phases. Similar pregnancy rates (30–36.4%) were obtained from recipients receiving ET either in their late follicular or early luteal phases, regardless of embryo developmental stages. This study indicates that the available time window for ET in rhesus monkeys is from the late follicular to early luteal phases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512020     DOI: 10.1002/ajp.21017

Source DB:  PubMed          Journal:  Am J Primatol        ISSN: 0275-2565            Impact factor:   2.371


  7 in total

1.  Germline acquisition of Cas9/RNA-mediated gene modifications in monkeys.

Authors:  Yongchang Chen; Yiqiang Cui; Bin Shen; Yuyu Niu; Xiaoyang Zhao; Lei Wang; Jianying Wang; Wei Li; Qi Zhou; Weizhi Ji; Jiahao Sha; Xingxu Huang
Journal:  Cell Res       Date:  2014-12-23       Impact factor: 25.617

2.  TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys.

Authors:  Hailiang Liu; Yongchang Chen; Yuyu Niu; Kunshan Zhang; Yu Kang; Weihong Ge; Xiaojing Liu; Enfeng Zhao; Chencheng Wang; Shaoyun Lin; Bo Jing; Chenyang Si; Quan Lin; Xiaoying Chen; Haijun Lin; Xiuqiong Pu; Yingying Wang; Binlian Qin; Fang Wang; Hong Wang; Wei Si; Jing Zhou; Tao Tan; Tianqing Li; Shaohui Ji; Zhigang Xue; Yuping Luo; Liming Cheng; Qi Zhou; Siguang Li; Yi Eve Sun; Weizhi Ji
Journal:  Cell Stem Cell       Date:  2014-02-13       Impact factor: 24.633

3.  In Vitro Culture of Rhesus Macaque (Macaca mulatta) Embryos.

Authors:  Cathy Ramsey; Carol Hanna
Journal:  Methods Mol Biol       Date:  2019

4.  Cloning and base editing of GFP transgenic rhesus monkey and off-target analysis.

Authors:  Yu Kang; Shaoxing Dai; Yuqiang Zeng; Fang Wang; Pengpeng Yang; Zhaohui Yang; Youwei Pu; Zifan Li; Xinglong Chen; Baohong Tian; Wei Si; Weizhi Ji; Yuyu Niu
Journal:  Sci Adv       Date:  2022-07-22       Impact factor: 14.957

Review 5.  CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection.

Authors:  Jenna Kropp Schmidt; Matthew R Reynolds; Thaddeus G Golos; Igor I Slukvin
Journal:  Retrovirology       Date:  2022-08-10       Impact factor: 3.768

6.  Major histocompatibility complex class I haplotype diversity in Chinese rhesus macaques.

Authors:  Julie A Karl; Patrick S Bohn; Roger W Wiseman; Francesca A Nimityongskul; Simon M Lank; Gabriel J Starrett; David H O'Connor
Journal:  G3 (Bethesda)       Date:  2013-07-08       Impact factor: 3.154

7.  TALEN-based generation of a cynomolgus monkey disease model for human microcephaly.

Authors:  Qiong Ke; Weiqiang Li; Xingqiang Lai; Hong Chen; Lihua Huang; Zhuang Kang; Kai Li; Jie Ren; Xiaofeng Lin; Haiqing Zheng; Weijun Huang; Yunhan Ma; Dongdong Xu; Zheng Chen; Xinming Song; Xinyi Lin; Min Zhuang; Tao Wang; Fengfeng Zhuang; Jianzhong Xi; Frank Fuxiang Mao; Huimin Xia; Bruce T Lahn; Qi Zhou; Shihua Yang; Andy Peng Xiang
Journal:  Cell Res       Date:  2016-08-09       Impact factor: 25.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.